Jinzhao Zhai

Beijing, 100039, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Insulinoma-associated Protein-1 as a Biomarker for Diagnosis of Small Cell Lung Cancer: A Meta-analysis.

Insulinoma-associated Protein-1 as a Biomarker for Diagnosis of Small Cell Lung Cancer: A Meta-analysis.

Journal: Pakistan journal of medical sciences
Published: December 16, 2025

Spatial distribution analysis of tertiary lymphoid structures in esophageal squamous cell carcinoma predicts patient survival and response to neoadjuvant chemo-immunotherapy.

Spatial distribution analysis of tertiary lymphoid structures in esophageal squamous cell carcinoma predicts patient survival and response to neoadjuvant chemo-immunotherapy.

Journal: Journal of translational medicine
Published: September 16, 2025

Clinical outcomes of a quadruplet regimen (immunotherapy, chemotherapy, anti-angiogenic therapy) in non-small cell lung cancer with EGFR exon 20 insertion mutations: a case series.

Clinical outcomes of a quadruplet regimen (immunotherapy, chemotherapy, anti-angiogenic therapy) in non-small cell lung cancer with EGFR exon 20 insertion mutations: a case series.

Journal: AME case reports
Published: September 09, 2025

Thermal modulation enhances antitumour immunity and improves immunotherapy responses in lung cancer.

Thermal modulation enhances antitumour immunity and improves immunotherapy responses in lung cancer.

Journal: Discover oncology
Published: August 21, 2025

PD-1/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: a real-world study and nomogram for survival prognosis.

PD-1/PD-L1 inhibitors monotherapy vs. combination therapy in elderly advanced NSCLC: a real-world study and nomogram for survival prognosis.

Journal: BMC pulmonary medicine
Published: March 24, 2025

Efficacy and safety of low-intensity chemotherapy combined with immunotherapy in elderly patients with locally advanced and metastatic non-small cell lung cancer: a retrospective analysis.

Efficacy and safety of low-intensity chemotherapy combined with immunotherapy in elderly patients with locally advanced and metastatic non-small cell lung cancer: a retrospective analysis.

Journal: BMC cancer
Published: January 14, 2025

A Comparative Study of the Efficacy and Safety of Immune Monotherapy versus 
Immunotheray Combined with Chemotherapy in Elderly Patients Aged 75 Years 
and Above with Advanced Non-small Cell Lung Cancer

A Comparative Study of the Efficacy and Safety of Immune Monotherapy versus 
Immunotheray Combined with Chemotherapy in Elderly Patients Aged 75 Years 
and Above with Advanced Non-small Cell Lung Cancer

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: November 04, 2024

Current Status and Prospect of PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy 
in Elderly Patients with Advanced NSCLC

Current Status and Prospect of PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy 
in Elderly Patients with Advanced NSCLC

Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: June 16, 2024

Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.

Clinicopathological characteristics and prognostic significance of HDAC11 protein expression in non-small cell lung cancer: a retrospective study.

Journal: Translational lung cancer research
Published: March 28, 2022

First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trials.

First-line PD-1/PD-L1 inhibitors plus chemotherapy versus bevacizumab plus chemotherapy for advanced non-squamous non-small cell lung cancer: A Bayesian network meta-analysis of randomized controlled trials.

Journal: Cancer medicine
Published: August 21, 2021
Showing 1-10 of 10

Last Updated: 09/26/2026